İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Makale detayı · 2023 · article

Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions.

Dergi Respiratory Investigation
ISSN2212-5345
YÖKSİS OpenAlex
Yıl2023
Atıf12OpenAlex
Atıf13Semantic Scholar
Yüzdelik%87,1
FWCI1,941,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q2
DOI10.1016/j.resinv.2023.04.007 OpenAlexOpenAlex kaydı

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıRespiratory investigation
  • Katalog eşleşmesi (ISSN)Respiratory Investigation
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

12atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 9 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 Geriatric nutrition risk index as an indicator of acute exacerbation and mortality risk in patients with idiopathic pulmonary fibrosisAtıf 2 · OpenAlex
  2. 2026 Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world studyAtıf 0 · OpenAlex
  3. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosisAtıf 0 · OpenAlex
  4. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosisAtıf 0 · OpenAlex
  5. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosisAtıf 0 · OpenAlex
  6. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosisAtıf 0 · OpenAlex
  7. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosisAtıf 0 · OpenAlex
  8. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosisAtıf 0 · OpenAlex
  9. 2025 Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosisAtıf 0 · OpenAlex

Yazarlar

12
  1. AYKUT ÇİLLİ 1
  2. NESRİN ÖCAL SAĞLIK BİLİMLERİ ÜNİVERSİTESİ 2
  3. FATİH ÜZER 3
  4. NECMİYE FUNDA COŞKUN 4
  5. CAN SEVİNÇ DOKUZ EYLÜL ÜNİVERSİTESİ 5
  6. AHMET URSAVAŞ 6
  7. PINAR YILDIZ 7
  8. PELİN PINAR DENİZ 8
  9. NİLGÜN YILMAZ DEMİRCİ 9
  10. gamze özbey 10
  11. AHMET YURTTAŞ 11
  12. İSMAİL HANTA 12